Not available in the U.S.
Mechanism of action: Hydroquinidine ballicule
What it isDihydro derivative of quinidine, a class IA sodium channel blocker; Brugada syndrome and arrhythmia.
Why this oneAlong with quinidine it is one of the few drugs that suppresses ventricular fibrillation in Brugada syndrome.
What limits itQT prolongation and cinchonism as for quinidine. Not US-approved.
Molecular structure: Hydroquinidine
FDA-approved for
- cardiac arrhythmias (non-US)
Off-label
- Brugada syndrome
- arrhythmias (approved in France)
Principal riskQT prolongation and cinchonism
Classes and tags
Clinical profile
Therapeutic safety burden4 / 4
Overdose danger4 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades4 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4
Defining liabilityTorsades, conduction block and potentially lethal proarrhythmia
Open Hydroquinidine in the interactive console ↗